Authors


Jingning Li

Latest:

Release and Stability Testing Programs for a Novel Virus-Like Particle Vaccine

Release testing involves both standard potency assays and unique assays (particle size, NA activity) developed to ensure the physical, chemical, and biological stability of this type of vaccine.


Crystal Chan

Latest:

Advancing Adjuvants and Vaccine Delivery Systems for Better Vaccination Strategies

This article presents ongoing research at VIDO-InterVac for the development of safer and more effective adjuvants. These include adjuvants that stimulate innate immunity in the body and combination adjuvants.


Kenneth Seamon

Latest:

Biologics: Can There Be Abbreviated Applications, Generics, or Follow-On Products?

In this question-and-answer discussion of "generic" biologics, the authors contend small changes in manufacturing of biologics dramatically affect the safety and efficacy of the therapeutic molecule.


Thibaud S. Stoll

Latest:

Harvesting the Benefits of LEAN in Biopharmaceutical Manufacturing

A step-by-step approach is essential for successful implementation.



William B. Ershler

Latest:

Influenza Vaccine Enhancement with Immunomodulating Peptide Thymosin Alpha 1

Clinical studies have shown that treatment with thymosin alpha 1 increases response to vaccination.


Maria Wik

Latest:

Best Practices for Microbial Fermenter Equipment Characterization

Wet testing of microbial fermenters allows for a greater understanding of the equipment's capabilities.


Robin A. Heller-Harrison

Latest:

Managing Cell Line Instability and Its Impact During Cell Line Development

By considering stability as part of the cell line selection and cell banking paradigm, we can ensure that instability problems are not observed during clinical or commercial manufacturing.


Denis Boyle, PhD

Latest:

Advances in Monoclonal Antibody Purification

New technologies and adaptations of existing technologies can improve platform processes.



Esteban Rivera

Latest:

Improving Tangential Flow Filtration Yield

Best methods to maximize product yield and membrane lifetime to enhance a tangential flow filtration process.


Mark J. Stramaglia

Latest:

Strategies for Sourcing Animal-Origin Free Cell Culture Media Components

How to successfully balance patient safety with supply-chain management


Marta Jimenez-Aquino

Latest:

Pharmaceutical Quality Success: It's All About Management

Engaging executive leadership in the quality process is the key to compliance success.


James Weidner

Latest:

Chromatography Optimization Strategy

Robust packing procedures can improve process performance and increase resin lifetime.



Anne Aunins

Latest:

Integrating CMC Document Preparation into the Development Process for Vaccine INDs

Vaccine process development is complex, and so are the documents required before clinical trials begin. Technical writers and editors can effectively coordinate the timely authoring, reviewing, and auditing of regulatory documents, minimizing filing delays.


Thomas P. Loisel

Latest:

Solutions for Purification of Fc-fusion Proteins

When platform processes are applied to fusion molecules, innovation and flexibility are needed.





Paul Johnson

Latest:

The Development and Application of a Monoclonal Antibody Purification Platform

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.


Thomas Mueller-Spaeth, PhD

Latest:

Increasing Capacity Utilization in Protein A Chromatography

A twin-column periodic countercurrent capture process that combines an efficient sequential, countercurrent loading process with a minimal twin-column hardware configuration is described.



Benedicte Lebreton

Latest:

Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies

Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.


Suma Ray, PhD

Latest:

Key Considerations for Development and Production of Vaccine Products

Challenges of vaccine development include regulatory, technical, and manufacturing hurdles in translating a vaccine candidate into a commercial product.



Satyam S. Nampalli

Latest:

Strategies for Sourcing Animal-Origin Free Cell Culture Media Components

How to successfully balance patient safety with supply-chain management


Gill A. Webster, PhD

Latest:

The Therapeutic Vaccine Potential of MIS416 Adjuvant

This article discusses the potential of MIS416 adjuvant, a vaccine adjuvant and immunogen co-delivery system, to provide adequate immunostimulation to overcome host factors that may limit the success of therapeutic vaccines.


Wang-Ting Hsieh, PhD

Latest:

Detection of Cache Valley Virus in Biologics Manufactured in CHO Cells

Avoid manufacturing failures by effective viral inactivation.


Archie Lovatt, PhD

Latest:

Detection of Cache Valley Virus in Biologics Manufactured in CHO Cells

Avoid manufacturing failures by effective viral inactivation.

© 2025 MJH Life Sciences

All rights reserved.